Results
24,511 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 14 | Pitigoi CosminChief Financial Officer |  FLYWFlywire CorpOpen-market sale · 10b5-1 plan | SELL | $122K 5,916 sh | Nov 6, 2026 |
Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 14 | Pitigoi CosminChief Financial Officer | FLYWFlywire Corp Open-market sale · 10b5-1 plan | SELL | $122K 5,916 sh | Nov 6, 2026 |
| 13 | Kelly Roland ThomasChief Legal Officer and GC |  VELVelocity Financial, Inc.Open-market sale · 10b5-1 plan | SELL | $58K 3,200 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Robinson ElliottDirector |  HNGEHinge Health, Inc.Open-market sale | SELL | — 0 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Shimanovsky Boris F.EVP, Chief Technology Officer |  ZIPZIPRECRUITER, INC.Open-market sale · 10b5-1 plan | SELL | $141K 30.0K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO |  UTHRUNITED THERAPEUTICS CorpOpen-market sale · 10b5-1 plan | SELL | $95K 160 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $184K 320 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $182K 310 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $186K 320 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $193K 330 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $70K 120 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $139K 240 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $184K 320 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Patel Sanj KDirector, CHAIRMAN & CEO |  KNSAKiniksa Pharmaceuticals International, plcOpen-market sale · 10b5-1 plan | SELL | $135K 1,460 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 13 | Robinson ElliottDirector | HNGEHinge Health, Inc. Open-market sale | SELL | — 0 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $186K 320 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $180K 320 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $127K 221 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $71K 120 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $183K 306 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $89K 156 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $119K 200 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $142K 237 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $159K 280 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $93K 160 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $215K 375 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $166K 280 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $100K 167 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Robinson ElliottDirector | HNGEHinge Health, Inc. Open-market sale | SELL | — 0 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 12 | Johnson Sandra K.Director |  RMRegional Management Corp.Open-market sale · 10b5-1 plan | SELL | $77K 2,009 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 12 | Dempsey Tyler BGeneral Counsel |  RPAYRepay Holdings CorpOpen-market sale · 10b5-1 plan | SELL | $119K 25.0K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 12 | Tan FionaChief Technology Officer |  WWayfair Inc.Open-market sale · 10b5-1 plan | SELL | $859K 7,000 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 12 | Rubenstein Andrew H.Director, 10% Owner, Chairman |  ACELAccel Entertainment, Inc.Open-market sale · 10b5-1 plan | SELL | $518K 40.0K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 12 | Buckley Sean PatrickSee Remarks |  MGNIMAGNITE, INC.Open-market sale · 10b5-1 plan | SELL | $297K 11.0K sh | Nov 6, 2026 traded Nov 5, 2026 |
| 11 | Mansueto Joseph DDirector, Executive Chairman, 10% Owner |  MORNMorningstar, Inc.Open-market sale · 10b5-1 plan | SELL | $467K 1,896 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 11 | Fraga FranciscoEVP, CIO and CTO |  MCKMCKESSON CORPOpen-market sale · 10b5-1 plan | SELL | $717K 650 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 11 | Pitigoi CosminChief Financial Officer | FLYWFlywire Corp Open-market sale · 10b5-1 plan | SELL | $15K 700 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 11 | Altschuler RandolphDirector |  XMTRXometry, Inc.Open-market sale · 10b5-1 plan | SELL | $259K 2,358 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 11 | Mansueto Joseph DDirector, Executive Chairman, 10% Owner | MORNMorningstar, Inc. Open-market sale · 10b5-1 plan | SELL | $557K 2,248 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 11 | Maheshwari AnshulChief Op & Financial Officer |  SIBNSI-BONE, Inc.Open-market sale · 10b5-1 plan | SELL | $81K 3,247 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 11 | Fairbank Richard DDirector, Chairman and CEO |  COFCAPITAL ONE FINANCIAL CORPOpen-market sale · 10b5-1 plan | SELL | $523K 2,502 sh | Nov 6, 2026 traded Nov 4, 2026 |